WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹249 Cr | ₹172 Cr | ₹121 Cr | ₹94 Cr | ₹93 Cr |
What is the latest Total Current Liabilities ratio of WINDLAS BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹249 Cr |
| Mar2024 | ₹172 Cr |
| Mar2023 | ₹121 Cr |
| Mar2022 | ₹94 Cr |
| Mar2021 | ₹93 Cr |
How is Total Current Liabilities of WINDLAS BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹249 Cr | 45.24 | |
| Mar2024 | ₹172 Cr | 41.66 | |
| Mar2023 | ₹121 Cr | 29.00 | |
| Mar2022 | ₹94 Cr | 0.61 | |
| Mar2021 | ₹93 Cr | - | |
Compare Total Current Liabilities of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹1,769.7 Cr | 1.8% | 6.4% | -11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 1.8% |
6.4% |
-11.4% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses